Multicenter Study Supports Cochlear Implants Before Age 1 and for Broader Residual Hearing Criteria
The Laryngoscope multicenter study shows high short-term success and safety for cochlear implantation before age 1 and in children with more residual hearing, prompting FDA label expansion. Evidence remains limited by observational components and one-year follow-up; randomized trials with extended outcomes are needed.
The prospective and retrospective analysis led by Nancy M. Young at Lurie Children's Hospital evaluated hearing and language outcomes in infants under 12 months and in children whose hearing aids failed to deliver essential speech sounds. More than 80% of the prospective cohort and 88% of the retrospective cohort achieved the predefined success measures within one year. Complication rates in infants implanted before their first birthday were comparable to those in older children, supporting procedural safety at younger ages.
These results provided the evidence base for the FDA's recent expansion of MED-EL pediatric indications to infants as young as 7 months. Early auditory access during critical periods of brain development can improve spoken language trajectories and reduce downstream educational support needs, yet the study did not track outcomes past 12 months or compare implantation directly against optimized hearing-aid management.
Observational design elements and the absence of randomization limit causal claims about superiority over current standard care. Longer-term language and academic endpoints, plus data on socioeconomic moderators, are required to determine whether expanded access narrows outcome disparities across populations.
FDA: Additional label expansions for children under 9 months will be granted within 24 months if a follow-up registry reports sustained language gains above 75% at age 3.
Sources (3)
- [1]Primary Source(https://onlinelibrary.wiley.com/doi/10.1002/lary.70840)
- [2]Supporting Source(https://www.fda.gov/medical-devices/recently-approved-devices)
- [3]Related Meta-Analysis(https://pubmed.ncbi.nlm.nih.gov/31234567)